Professional Documents
Culture Documents
Cell Bank
Characterisation
Virus Permissivity for Cell Lines
Commonly Used in the In Vitro
In Vitro Tests for Adventitious Viruses
Adventitious Agent Test
I dentifying unknown viruses still represents
a significant challenge for virologists, and
is the main reason only a fraction of viruses C ell Line
E xample viruses detected
circulating have been identified. Virus growth MRC-5 Ortho- and Paramyxovirues,
in tissue culture is not always possible, selected Picornaviruses,
with viruses often displaying distinct tissue Herpesviruses
tropisms. Certain viruses may also fail to
Vero SV40, Vesicular stomatitis
demonstrate any visible cytopathic effect even
virus, Adenoviruses,
when growing to high titres, and thus virus
Herpesviruses, Reoviruses
growth may not be immediately apparent.
Despite these challenges however, certain cell HeLa Adenoviruses,
lines have proven useful in the detection of a Coxsackieviruses, Poliovirus
wide range of potential virus contaminants, A9 Mice minute virus,
including Vero, MRC-5 and HeLa cells. Adenoviruses
BT Bovine Adenoviruses,
The in vitro assay for detection of viruses uses Herpesviruses,
a selection of cell lines with a proven history in Polyomaviruses and
the detection of a wide range of potential virus Arboviruses
contaminants. It is used both in the testing and
characterisation of recombinant cell banks, as In vivo Tests for Adventitious Viruses
I
well as in the testing of raw materials (e.g. bo- n vivo adventitious agent tests remain one
vine serum). No single cell culture based assay of the critical cell bank characterisation tests
can provide guarantees for the detection of all despite ethical concerns around the use of
potential contaminants, but rather the aim is animals for testing. The main advantage of
to cover a broad spectrum. Thus testing is rou- the in vivo test is the broad range of viruses
tinely performed on a minimum of 3 cell lines, detected. The use of this test is restricted
almost always including Vero and MRC-5 cells, primarily to the characterisation of master cell
and the third cell line being selected based on banks, and ethical concerns normally preclude
the species of origin of the production cell line the use of this test as a general QC release test
or raw material. The table below provides an for biopharmaceutical products. For products
overview of commonly used cell lines for the of higher risk, however, lot release testing
in vitro assay along with a selection of poten- using the in vivo test may be requested.
tial viral contaminants likely to be detected.
ViruSure GmbH
Tech Gate Science and Technology Park,
Donau City Strasse 1, A-1220 Vienna, Austria
Telephone: +43-1-2699-120
Telefax: +43-1-2699-12022
E-Mail: andy_bailey@virusure.com
Page 1 virusure.com
Other QC Virus Safety Retrovirus Testing
In vitro adventitious agent testing also ViruSure can offer a range of retrovirus testing
plays an important role the lot release of of services to service the above regulatory
recombinant biopharmaceutical products requirements, including:
and is required at the following stages of • Retrovirus infectivity tests
biopharmaceutical product development and
production: • FPERT Retrovirus testing
• Electron microscopy for characteri-
• Master cell bank or virus seed bank sation and quantification of retro-
testing virus particles
• Working cell bank testing • Co-cultivation assays
• Production lot release testing